Company Data
BioVie Inc.
Ticker
BIVI
Current Price
$1.21 40.37%
Market Cap
$22.3M
Price Target
Refer to Report
Volume
8.7M
52wk Range
$0.62 - $7.5
Overview
BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.